Maureen Dubreuil, MD, MSc.

Dr. Dubreuil is a rheumatologist in Boston, specializing in Spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. In 2013, she was awarded the Arthritis Foundation Clinical to Research Transition Award and 2016, she began work on a K23-funded project to study patient preferences, and the cost-effectiveness of treatment modalities for spondyloarthritis, to inform both clinical care and policy decisions. She serves as Education Chair and Board Member for the Spondyloarthritis Research and Treatment Network (SPARTAN), is a Medical Advisor for the Spondylitis Association of America, and is a member of the Assessment of Spondyloarthritis International Society (ASAS). She is a site investigator for the international CLASSIC study and the PULSAR spondyloarthritis registry.

Member
Boston University
Arthritis & Autoimmune Diseases Research Center


VA Boston Healthcare System




Delay in diagnosis of ankylosing spondylitis: Do race, ethnicity or social determinants of health matter?
01/01/2023 - 12/31/2024 (PI)
Arthritis Foundation


Career Development Bridge Funding Award: R Bridge
11/01/2022 - 10/30/2024 (PI)
Rheumatology Research Foundation


SPARTAN Referral Recommendations
07/01/2021 - 06/30/2023 (PI)
SpondyloArthritis Research and Treatment Network


Risk of fractures, joint replacements and adverse pregnancy outcomes in ankylosing spondylitis
07/01/2020 - 06/30/2023 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5R03AR076495-02

Effects of Janus kinase inhibitors on structural and safety outcomes in spondyloarthritis
06/16/2022 - 06/16/2023 (PI)
Pfizer, Inc.


Classification of Axial SpondyloarthritiS Inception Cohort (CLASSIC)
12/23/2019 - 12/22/2022 (PI)
SpondyloArthritis Research and Treatment Network


Establishing The Value of Treatment Strategies in Spondyloarthritis
05/01/2016 - 04/30/2022 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5K23AR069127-05

Cardiovascular disease and diabetes in Ankylosing Spondylitis
07/01/2013 - 12/30/2015 (PI)
Arthritis Foundation



Boston University Advanced Fellowship in Psoriatic Arthritis Clinical and Research Excellence
07/01/2020 - 06/30/2022 (PI)
Pfizer, Inc


Title

Boston University Clinical and Translational Science Institute
01/01/2019 - 12/31/2020 (PI)
BU CTSI

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Yau MS, Dubreuil M, Li S, Inamdar V, Peloquin C, Felson DT. Validation of knee osteoarthritis case identification algorithms in a large electronic health record database. Osteoarthr Cartil Open. 2022 Mar; 4(1).View Related Profiles. PMID: 35601472; PMCID: PMC9122022; DOI: 10.1016/j.ocarto.2021.100229;
     
  2. Liew JW, Jafarzadeh SR, Dubreuil M, Heckbert SR, Mooney SJ, Brown MA, Ishimori ML, Reveille JD, Ward MM, Weisman MH, Gensler LS. The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort. J Rheumatol. 2022 03; 49(3):274-280.View Related Profiles. PMID: 34853088
     
  3. Stovall R, Peloquin C, Felson D, Neogi T, Dubreuil M. Relation of NSAIDs, DMARDs, and TNF Inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee Arthroplasty. J Rheumatol. 2021 Dec; 48(12):1892.View Related Profiles. PMID: 34853165
     
  4. Calivà F, Namiri NK, Dubreuil M, Pedoia V, Ozhinsky E, Majumdar S. Studying osteoarthritis with artificial intelligence applied to magnetic resonance imaging. Nat Rev Rheumatol. 2022 02; 18(2):112-121. PMID: 34848883
     
  5. Bekele DI, Cheng E, Reimold A, Geier C, Ganuthula K, Walsh JA, Clegg DO, Dubreuil M, Kaushik P, Ng B, Chang E, Duong R, Park J, Kerr GS. Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis. Rheumatol Int. 2022 11; 42(11):1925-1937. PMID: 34724089
     
  6. Fillmore N, Bell S, Shen C, Nguyen V, La J, Dubreuil M, Strymish J, Brophy M, Mehta G, Wu H, Lieberman J, Do N, Sander C. Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study. PLoS One. 2021; 16(10):e0259061.View Related Profiles. PMID: 34710137; PMCID: PMC8553043; DOI: 10.1371/journal.pone.0259061;
     
  7. Aoyagi K, Neogi T, Peloquin C, Dubreuil M, Marinko L, Camarinos J, Felson DT, Kumar D. Association of Physical Therapy Interventions With Long-term Opioid Use After Total Knee Replacement. JAMA Netw Open. 2021 10 01; 4(10):e2131271.View Related Profiles. PMID: 34705013; PMCID: PMC8552057; DOI: 10.1001/jamanetworkopen.2021.31271;
     
  8. Zheng C, Fillmore NR, Ramos-Cejudo J, Brophy M, Osorio R, Gurney ME, Qiu WQ, Au R, Perry G, Dubreuil M, Chen SG, Qi X, Davis PB, Do N, Xu R. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimers Dement. 2022 Jun; 18(6):1248-1259.View Related Profiles. PMID: 34569707; PMCID: PMC8957621; DOI: 10.1002/alz.12465;
     
  9. Meer E, Thrastardottir T, Wang X, Dubreuil M, Chen Y, Gelfand JM, Love TJ, Ogdie A. Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies. J Rheumatol. 2022 01; 49(1):53-59. PMID: 34334358
     
  10. Stovall R, Peloquin C, Felson D, Neogi T, Dubreuil M. Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study. BMC Rheumatol. 2021 Jul 29; 5(1):36.View Related Profiles. PMID: 34321112; PMCID: PMC8320220; DOI: 10.1186/s41927-021-00207-1;
     
Showing 10 of 51 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 51 publications over 12 distinct years, with a maximum of 13 publications in 2021

YearPublications
20091
20101
20121
20134
20141
20152
20165
20175
20187
20194
20207
202113

2020-2022 NIH/NIAMS R03: Risk of Fractures & Joint Replacement Surgeries w/TNF-inhibitors in Ank. Spondylitis
2018 Spondylitis Association of America: Early Career Investigator Award
2018 Spondyloarthritis Research and Treatment Network Seed Grant Awardee
2017 Boston University: Evans Junior Merit Award
2016-2021 NIH/NIAMS K23: Establishing the Value of Treatment Strategies in Ankylosing Spondylitis
2016-2020 Boston University School of Public Health and Optum Labs Visiting Scholar
2015-2020 Boston University Department of Medicine: Career Investment Award
2013-2015 Arthritis Foundation: Research Scientist Development Award
2009 Gold Humanism in Medicine Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Spondyloarthritis, Ankylosing
Psoriatic Arthritis
Epidemiology
Pharmacoepidemiology
NSAIDs
Spondyloarthropathies
Spondyloarthritides, Ankylosing

I have mentored Master-level SPH students and fellows in projects related to epidemiology of rheumatologic diseases and pharmacoepidemiology. These projects have culminated in publications, a Master degree thesis, as well as poster and oral presentations at national meetings. I hope to continue mentoring trainees who have interests in epidemiology related to specific research projects, development of research themes, or development of grant applications.

Available to Mentor as: (Review Mentor Role Definitions):
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
Dubreuil's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department